Stay tuned and follow the latest developments and news in Molecular Oncology.
W4O Hellas & ARTE in collaboration with Genekor Medical S.A give women the opportunity to do a Free Genetic Test for hereditary predisposition to breast-ovarian cancer.
The company Genekor actively participates in the new gene control program implemented by Women in Oncology – W4O Hellas in collaboration with the Non-Profit Company “ARTE”. The program aims to detect hereditary predisposition to breast and ovarian cancer, providing free genetic tests to selected women throughout Greece.
In this way, the program seeks to economically cover the cost of genetic testing, offering the possibility to treating physicians to make the best decisions and provide appropriate guidance to women who have an increased risk of breast-ovarian cancer.
Read in detail the inclusion criteria for free genetic testing of the W4O Hellas-ARTE Program :
https://www.genekor.com/media/1968/νέο-πρόγραμμα-γονιδιακού-ελέγχου.pdf